In order to investigate if similar effects could be observed in vivo, we utilised CRISPR/Cas9 editing technology to knockout the mouse IFIT3 gene (Figure S4A–C) and induced a SSc mouse model with bleomycin (Figure 8A). Here, IFIT3 is linked to systemic sclerosis.